Journal of Pharmaceutical Policy and Practice

Taylor & Francis Group

Journal websitePeer review: Double-blind review

Evaluation status available after sign-in

About the journal

Journal of Pharmaceutical Policy and Practice is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,630 USD. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher: Taylor & Francis Group
ISSN: 2052-3211
Country: United Kingdom
Languages: english
Access: Open access
Declared publication charge: 2,630 USD
Articles in DOAJ: 959
Declared review time: 14 weeks
Declared peer-review model: double_blind
Official website: https://www.tandfonline.com/journals/jppp20

Index listings

DOAJ · 2015-07-08
PUBMED · 2015-10-05

Indexing: DOAJ · PUBMED
APC: 2,630 USD
Declared review time (DOAJ): 14 weeks — journal-declared only (not measured)
Activity (OpenAlex): Active — latest works 2026
PublishLens list status: Shown after sign-in
Counts for promotion at your university?: Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

959

Most recent article

last month

Average review time (journal-declared via DOAJ)

14weeks

Works in OpenAlex

1142

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

i10-index

426

From OpenAlex open data (CC0).

Editorial & policy13

Last DOAJ review date: 2025-01-13
Added to DOAJ: 2015-07-08
Declared plagiarism screening: Declared
Other fees beyond APC: No
Declared digital preservation: CLOCKSSLOCKSSPorticoNational Digital Preservation ProgramChina
Observed digital preservation (Keepers registry)— snapshot 2026-10-05: CLOCKSSPortico
Editorial board: Official page ↗
Norwegian register (HK-dir)— 2026: Level 1 — approved scholarly channel
Open references deposited at Crossref: 98%
ORCID iDs in current deposits: 89%
Enrolled in Crossref Similarity Check: ✓
Deposits licence metadata at Crossref: ✓
APC waiver policy: View policy
Peer-review policy: View policy

Identity & continuity4

Alternate titles: JoPPP
Source type: journal
NLM unique ID (PubMed): 101627192
Society affiliations: Commonwealth Pharmacists Association.

Classification4

Subjects (DOAJ)

Medicine: Therapeutics. PharmacologyMedicine: Pharmacy and materia medica

LCC codes

RM1-950RS1-441

Subject areas

Pharmaceutical Economics and Policy
Pharmaceutical Economics and Policy
Pharmaceutical Economics and Policy
Pharmacy and Medical Practices
Pharmaceutical Practices and Patient Outcomes
Pharmaceutical Practices and Patient Outcomes
Antibiotic Use and Resistance
Pharmaceutical Quality and Counterfeiting

Show all subjects (75)

Antibiotic Use and Resistance
Pharmaceutical Quality and Counterfeiting
Pharmaceutical Practices and Patient Outcomes
Health Systems, Economic Evaluations, Quality of Life
Health Systems, Economic Evaluations, Quality of Life
Pharmaceutical Quality and Counterfeiting
Health Systems, Economic Evaluations, Quality of Life
Healthcare Systems and Reforms
Antibiotic Use and Resistance
Medication Adherence and Compliance
Medication Adherence and Compliance
Healthcare Regulation
Pharmaceutical industry and healthcare
Pharmaceutical studies and practices
Pharmaceutical studies and practices
Pharmacovigilance and Adverse Drug Reactions
Pharmacovigilance and Adverse Drug Reactions
Pharmacovigilance and Adverse Drug Reactions
Vaccine Coverage and Hesitancy
Healthcare Systems and Reforms
Healthcare Systems and Reforms
Vaccine Coverage and Hesitancy
Global Maternal and Child Health
Global Maternal and Child Health
Medication Adherence and Compliance
Pharmaceutical industry and healthcare
Global Health Workforce Issues
Pharmaceutical industry and healthcare
Vaccine Coverage and Hesitancy
Patient Safety and Medication Errors
COVID-19 and Mental Health
COVID-19 and Mental Health
Patient Safety and Medication Errors
Patient Safety and Medication Errors
Antibiotic Resistance in Bacteria
Supply Chain and Inventory Management
Economic and Financial Impacts of Cancer
Economic and Financial Impacts of Cancer
Pharmaceutical studies and practices
Innovations in Medical Education
SARS-CoV-2 and COVID-19 Research
SARS-CoV-2 and COVID-19 Research
Healthcare Policy and Management
SARS-CoV-2 and COVID-19 Research
COVID-19 and Mental Health
Complementary and Alternative Medicine Studies
Competency Development and Evaluation
Pharmaceutical and Antibiotic Environmental Impacts
COVID-19 Clinical Research Studies
Healthcare professionals’ stress and burnout
Pharmaceutical and Antibiotic Environmental Impacts
Biosimilars and Bioanalytical Methods
Healthcare professionals’ stress and burnout
Biosimilars and Bioanalytical Methods
Opioid Use Disorder Treatment
Healthcare professionals’ stress and burnout
COVID-19 Clinical Research Studies
Antibiotic Resistance in Bacteria
Biotechnology and Related Fields
Innovations in Medical Education
Innovations in Medical Education
Fisheries and Aquaculture Studies
Fisheries and Aquaculture Studies
Antibiotic Resistance in Bacteria
Biotechnology and Related Fields
Blood Pressure and Hypertension Studies
Healthcare Policy and Management

Keywords (DOAJ)

pharmaceutical policy
pharmacy
pharmacoeconomics
health economics

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…

How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJL DOAJ